Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD

Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT), but the effectiveness of this monotherapy is still very low. A possible mechanism of resistance...

詳細記述

保存先:
書誌詳細
出版年:Front Immunol
主要な著者: Yao, Sun, Jianlin, Chen, Zhuoqing, Qiao, Yuhang, Li, Jiangwei, Hu, Guoliang, Hu, Hongmei, Ning, Bin, Zhang, Liangding, Hu
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2021
主題:
Immunology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8047076/
https://ncbi.nlm.nih.gov/pubmed/33868266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.639217
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料